Sanyo Chemical Group At STLE in Atlanta
We are heading to STLE in Atlanta, May 18th – 22nd! Sanyo Chemical Group has been innovating since 1949, developing 3,000+ performance chemicals that power industries from healthcare to mobility.…
Read MoreNews
Sanyo Chemical’s Silk-Elastin Shows Promise in Wound Healing Clinical Trial Results Published in Scientific Reports — Seeking U.S. Partners for Market Entry —
KYOTO, JAPAN — [April 7, 2025] — Sanyo Chemical’s Silk-Elastin, a novel recombinant protein, has demonstrated exceptional efficacy and safety in clinical trials for chronic wound healing. The findings, published…
Read MoreJoin Us At The Clean Fuels Conference 2025
Discover the latest innovations in Clean Fuels! Don’t miss out on the opportunity to meet industry experts, network with other professionals, and discover the latest products and services in Clean…
Read MoreExhibition information －SPIE AR | VR | MR
January 27 to 29, San Francisco, USA －Sanyo Chemical Industries, Ltd. will be exhibiting at SPIE AR | VR | MR, an international exhibition on optical components. The exhibition organized by…
Read MoreSanyo Chemical Consecutively Selected for the FTSE Blossom Japan Index and FTSE Blossom Japan Sector Relative Index
Sanyo Chemical announced that it has been selected for the FTSE Blossom Japan Index and the FTSE Blossom Japan Sector Relative Index. FTSE Blossom Japan Index marks the second consecutive…
Read MoreInvestigator Initiated Trial Confirms Safety of Silk-Elastin for Meniscus Injury－Multi-Center Collaborative Corporate Clinical Trial to Seek Approval for Meniscal Repair and Regeneration Medical Devices－
Sanyo Chemical Industries, Ltd. and Hiroshima University are pleased to announce that an investigator-initiated clinical trial was conducted targeting patients with meniscus injuries (meniscus suture) using new treatment method using…
Read MoreConfirmation of High Safety and Efficacy of Artificial Protein Silk-Elastin® in Chronic Wound Healing－Innovative Material for Chronic Wound Healing Moves Toward to Regulatory Approval－
Sanyo Chemical Industries, Ltd. and Professor Naoki Morimoto of the Department of Plastic and Reconstructive Surgery, Kyoto University Hospital, are pleased to announce positive results from a corporate clinical trial…
Read MoreSanyo Chemical Signs MOU with Econic to Advance CO2-Based Polyols for Carbon Neutrality
Sanyo Chemical Industries, Ltd. has signed a memorandum of understanding (MOU) with Econic Technologies Ltd, a UK-based deep-tech company focused on renewable carbon. Sanyo Chemical will assess Econic’s technology for…
Read MoreJoint Exhibition Information –NPE 2024 – The Plastics Show
Sanyo Chemicals will exhibit permanent antistatic agents, acid modified polyolefin and polyolefin wax in the booth of Toyota Tsusho America, Inc. at NPE 2024 – The Plastics Show, the largest…
Read MoreNotice of Withdrawal from Business of Subsidiary and Recording of Extraordinary Loss
Sanyo Chemical Industries, Ltd. (“we” or “the Company”) hereby announces that, based on resolutions adopted at the meetings of its Boards of Directors held on March 25, 2024, the Company…
Read More